849 related articles for article (PubMed ID: 21552419)
1. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of liver cancer stem cells.
Oishi N; Yamashita T; Kaneko S
Liver Cancer; 2014 May; 3(2):71-84. PubMed ID: 24944998
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma.
Jeng KS; Chang CF; Sheen IS; Jeng CJ; Wang CH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674932
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
Pang RW; Poon RT
Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
[TBL] [Abstract][Full Text] [Related]
5. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger protein X-linked promotes expansion of EpCAM
Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
[TBL] [Abstract][Full Text] [Related]
8. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
[TBL] [Abstract][Full Text] [Related]
9. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
[TBL] [Abstract][Full Text] [Related]
11. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
12. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
13. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
14. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
15. EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.
Khosla R; Rastogi A; Ramakrishna G; Pamecha V; Mukhopadhyay A; Vasudevan M; Sarin SK; Trehanpati N
Stem Cells Transl Med; 2017 Mar; 6(3):807-818. PubMed ID: 28176469
[TBL] [Abstract][Full Text] [Related]
16. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract][Full Text] [Related]
17. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J
Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
[TBL] [Abstract][Full Text] [Related]
19. miR-365 regulates liver cancer stem cells via RAC1 pathway.
Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
[TBL] [Abstract][Full Text] [Related]
20. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Sia D; Villanueva A; Friedman SL; Llovet JM
Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]